Literature DB >> 3084414

Immunohistochemical demonstration of induction of pyloric glands with low pepsinogen 1 (Pg 1) content in rat stomach by N-methyl-N'-nitro-N-nitrosoguanidine.

M Tatematsu, C Furihata, Y Mera, T Shirai, T Matsushima, N Ito.   

Abstract

Three groups of male Fischer rats were given single doses of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) at 160 mg (group 1), 80 mg (group 2) and 40 mg (group 3)/kg body weight by gastric intubation. A fourth group was given drinking water containing 100 micrograms/ml of MNNG for 2 weeks, and a fifth group served as a control. Rats were killed in weeks 5, 8 and 12. Serial sections of the pyloric mucosa were examined by paradoxical concanavalin A (Con A) staining and pepsinogen isozyme 1 (Pg 1) immunostaining. All pyloric glands contained class III mucin as detected by paradoxical Con A staining. Most pyloric glands had a high Pg 1 content, but a few stained only weakly if at all. The percentage and number (No./500 normal-looking pyloric glands) of pyloric glands with a low Pg 1 content were 50.0 and 0.2 +/- 0.4 (week 5), 87.5 and 0.5 +/- 0.4 (week 8) and 100.0 and 1.2 +/- 1.0 (week 12) in group 1, 50.0 and 0.2 +/- 0.3 (week 8) and 87.5 and 0.5 +/- 0.4 (week 12) in group 2, and 30.0 and 0.2 +/- 0.4 (week 12) in group 4. No pyloric glands with a low Pg 1 content were found in groups 3 and 5. Thus the results showed significant dose-dependent induction (P less than 0.05-0.01) of altered pyloric glands demonstrating reduced Pg 1 content and their earlier appearance in groups given higher doses of MNNG. The results suggest that the appearance of pyloric glands with a low Pg 1 content may be a preneoplastic change in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084414

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  5 in total

1.  Hexosaminidase-altered aberrant crypts, carrying decreased hexosaminidase alpha and beta subunit mRNAs, in colon of 1,2-dimethylhydrazine-treated rats.

Authors:  T Tsukamoto; H Fukami; S Yamanaka; A Yamaguchi; H Nakanishi; H Sakai; I Aoki; M Tatematsu
Journal:  Jpn J Cancer Res       Date:  2001-02

2.  Dose-dependent induction of both pepsinogen-altered pyloric glands and adenocarcinomas in the glandular stomach of C3H mice treated with N-methyl-N-nitrosourea.

Authors:  M Yamamoto; C Furihata; Y Fujimitsu; T Imai; K Inada; H Nakanishi; M Tatematsu
Journal:  Jpn J Cancer Res       Date:  1997-03

3.  Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method.

Authors:  Chie Furihata
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2021       Impact factor: 3.493

4.  Increased susceptibility to N-nitrosomethylurea gastric carcinogenesis in transforming growth factor alpha transgenic mice with gastric hyperplasia.

Authors:  S Tamano; J Jakubczak; H Takagi; G Merlino; J M Ward
Journal:  Jpn J Cancer Res       Date:  1995-05

5.  Synergism between sodium chloride and sodium taurocholate and development of pepsinogen-altered pyloric glands: relevance to a medium-term bioassay system for gastric carcinogens and promoters in rats.

Authors:  M Tatematsu; M Mutai; K Inoue; K Ozaki; C Furihata; N Ito
Journal:  Jpn J Cancer Res       Date:  1989-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.